# Novartis (NVS) P/S ratio: 5.5× today, 4-year history

URL: https://funkfolio.com/stock/NVS/ps-ratio

> Novartis (NVS) P/S ratio is 5.5× today, against 4.8× at the end of fiscal 2025. Its median over 4 fiscal year-ends is 4.6×.

---

## Novartis (NVS) P/S ratio

**P/S ratio today:** 5.5× as of Nov 18, 2026, 9:57 AM UTC

Novartis (NVS) trades at 5.5× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 4.8×. That is 24.2% higher than the 3.8× of fiscal 2024. Figures as of 18 Nov 2026, 09:57 UTC, from Yahoo Finance.

### Key facts

- **P/S ratio today:** 5.5×
- **P/S ratio, fiscal 2025:** 4.8×
- **Change on fiscal 2024:** +24.2%
- **Highest on record:** 4.8× fiscal 2025
- **Lowest on record:** 3.8× fiscal 2024
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 09:57 UTC. Statements from Yahoo Finance. Figures, not advice.

### Novartis P/S ratio, in more detail

Today's figure is 15.4% above the fiscal 2025 year-end.

Across the 4 fiscal year-ends on record (2022–2025), the highest was 4.8× in fiscal 2025 and the lowest 3.8× in fiscal 2024. Today's P/S ratio is above every one of the 4 fiscal year-ends on record; their median is 4.6×.

### P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

### Novartis P/S ratio, year by year

Novartis (NVS) P/S ratio by fiscal year

| Fiscal year | P/S ratio | Change | Year ended | Share price at year-end | Revenue per share |
| --- | --- | --- | --- | --- | --- |
| Today | 5.5× | — | Nov 18, 2026 | $159.13 | — |
| 2025 | 4.8× | 24.2% up | Dec 31, 2025 | $137.87 | $28.99 |
| 2024 | 3.8× | 15.4% down | Dec 31, 2024 | $97.31 | $25.42 |
| 2023 | 4.5× | 1.3% down | Dec 31, 2023 | $100.97 | $22.30 |
| 2022 | 4.6× | — | Dec 31, 2022 | $90.72 | $19.78 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

### How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

### P/S ratio at health care companies of similar size

P/S ratio of Novartis and comparable companies

| Company | P/S ratio |
| --- | --- |
| [AbbVie ABBV](https://funkfolio.com/stock/ABBV/ps-ratio) | 8.5× |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/ps-ratio) | 5.4× |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/ps-ratio) | 0.8× |
| Novartis NVS | 5.3× |
| [AstraZeneca AZN](https://funkfolio.com/stock/AZN/ps-ratio) | 4.8× |
| [Thermo Fisher Scientific TMO](https://funkfolio.com/stock/TMO/ps-ratio) | 5.7× |

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

### Novartis, figure by figure

- [Novartis market cap](https://funkfolio.com/stock/NVS/market-cap)
- [Novartis revenue](https://funkfolio.com/stock/NVS/revenue)
- [Novartis earnings](https://funkfolio.com/stock/NVS/earnings)
- [Novartis earnings per share (EPS)](https://funkfolio.com/stock/NVS/eps)
- [Novartis P/E ratio](https://funkfolio.com/stock/NVS/pe-ratio)
- [Novartis P/B ratio](https://funkfolio.com/stock/NVS/pb-ratio)
- [Novartis free cash flow](https://funkfolio.com/stock/NVS/free-cash-flow)
- [Novartis operating margin](https://funkfolio.com/stock/NVS/operating-margin)
- [Novartis dividend](https://funkfolio.com/stock/NVS/dividend)
- [Novartis shares outstanding](https://funkfolio.com/stock/NVS/shares-outstanding)
- [Novartis total debt](https://funkfolio.com/stock/NVS/total-debt)
- [Novartis cash on hand](https://funkfolio.com/stock/NVS/cash)
- [Novartis total assets](https://funkfolio.com/stock/NVS/total-assets)
- [Novartis return on equity (ROE)](https://funkfolio.com/stock/NVS/roe)
- [Novartis return on invested capital (ROIC)](https://funkfolio.com/stock/NVS/roic)

[Novartis (NVS) overview: price, valuation and scorecard](https://funkfolio.com/stock/NVS) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Novartis P/S ratio: questions and answers

**What is Novartis's P/S ratio?**

Novartis (NVS) trades at 5.5× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 4.8×. That is 24.2% higher than the 3.8× of fiscal 2024.

**Is Novartis's P/S ratio high or low compared with its own history?**

Today's P/S ratio is above every one of the 4 fiscal year-ends on record; their median is 4.6×.

**What are the highest and lowest P/S ratio figures on record for Novartis?**

Across the 4 fiscal year-ends on record (2022–2025), the highest was 4.8× in fiscal 2025 and the lowest 3.8× in fiscal 2024.

**How is Novartis's P/S ratio calculated?**

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Novartis it is on record here for 4 fiscal years, 2022 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

### Learn: P/S ratio

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [P/E ratio explained: what a high or low figure means](https://funkfolio.com/learn/stocks/pe-ratio)

  The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- [Revenue vs earnings vs free cash flow: what each tells you](https://funkfolio.com/learn/stocks/revenue-earnings-free-cash-flow)

  Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Novartis (NVS) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/NVS/ps-ratio

Underlying data: Yahoo Finance.
